Endothelial progenitor cells and cardiovascular events in patients with chronic kidney disease - A prospective follow-up study

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Lorenzen, Johan ^a   David, Sascha ^a   Bahlmann, Ferdinand H ^b   Groot, Kirstende ^a   Bahlmann, Elisabeth ^a   Kielstein, Jan T ^a   Haller, Hermann ^a   Fliser, Danilo ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTERIOGRAPHY; ARTERY OCCLUSION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CELL FUNCTION; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HEART INFARCTION; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT ASSESSMENT; PROSPECTIVE STUDY; STEM CELL; TRANSLUMINAL CORONARY ANGIOPLASTY; CHRONIC KIDNEY FAILURE; CYTOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; ENDOTHELIAL CELLS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RENAL DIALYSIS; STEM CELLS;

EID: 77955396864     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011477     Document Type: Article

References (26)

1. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, et al. (1999) Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med; 5: 434-438.
2. Dzau VJ, Gnecchi M, Pachori AS, Morello F, Melo LG (2005) Therapeutic potentialofendothelialprogenitor cells in cardiovascular diseases. Hypertension; 46: 7-18.
3. Leri A, Kajstura J (2005) Endothelial progenitor cells: unexpected disclosures. Circ Res; 97: 299-301.
4. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med; 348: 593-600.
5. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, et al. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res; 89: E1-7.
6. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, et al. (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation; 111: 2981-2987.
7. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med; 353: 999-1007.
8. de Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, et al. (2004) Uremia causes endothelial progenitor cell deficiency. Kidney Int; 66: 641-646.
9. Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, et al. (2004) Erythropoietin regulates endothelial progenitor cells. Blood; 103: 921-926.
10. Choi JH, Kim KL, Huh W, Kim B, Byun J, et al. (2004) Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol; 24: 1246-1252.
11. Chan CT, Li SH, Verma S (2005) Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol; 289: F679-684.
12. de Groot K, Bahlmann FH, Bahlmann E, Menne J, Haller H, et al. (2005) Kidney graft function determines endothelial progenitor cell number in renal transplant recipients. Transplantation; 79: 941-945.
13. Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology ofcardiovascular disease in chronic renal disease. Am J Kidney Dis 32 (Suppl 3): S112-S119.
14. Ritz E (2004) Atherosclerosis in dialyzed patients. Blood Purif; 22: 28-37.
15. Werner N, Nickenig G (2006) Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler Thromb Vasc Biol; 26: 257-266.
16. Fadini GP, de Kreutzenberg S, Agostini C, Boscaro E, Tiengo A, et al. (2009) A. Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis, Apr 5. [Epub ahead of print].
17. Fliser D, De Groot K, Bahlmann FH, Haller H (2004) Cardiovascular disease in renal patients: a matter of stem cells? Editorial Comment. Nephrol Dial Transplant; 19: 2952-2594.
18. Steiner S, Schaller G, Puttinger H, Fodinger M, Kopp CW, et al. (2005) History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients. Am J Kidney Dis; 46: 520-528.
19. Bahlmann FH, DeGroot K, Duckert T, Niemczyk E, Bahlmann E, et al. (2003) Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int; 64: 1648-1652.
20. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, et al. (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood; 102: 1340-1346.
21. Steiner S, Winkelmayer WC, Kleinert J, Grisar J, Seidinger D, et al. (2006) Endothelial progenitor cells in kidney transplant recipients. Transplantation; 81:599-606.
22. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, et al. (2001) HMG-CoA reductase inhibitors increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest; 108: 391-397.
23. Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, et al. (2005) Stimulation of endothelial precursor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension; 45: 526-529.
24. Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood ''endothelial progenitor cells'' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation; 107: 1164-1169.
25. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, et al. (2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation; 108: 2511-2516.
26. Gueler F, Gwinner W, Schiborr C, Martin M, Klos A, et al. (2005) Biocompatibility parameters of different dialysis membranes assessed during systemic inflammation. Blood Purificat 23: 196-202.